News & Events

  • September 25, 2018

    Nemaura Reports Positive Zero Finger-Stick Calibration Data for SugarBEAT® Continuous Glucose Monitor

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    September 18, 2018

    Nemaura Signs Letter of Intent for SugarBEAT® Commercial Launch in Qatar

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous...

    September 12, 2018

    Nemaura Reports Positive Interim Data from Clinic Portion of SugarBEAT® FDA Clinical Trial

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible...

    August 28, 2018

    Nemaura Medical Strengthens Manufacturing Team in Preparation for SugarBEAT® Commercial Launch.

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device...

    August 9, 2018

    Nemaura Medical Inc. Reports First Quarter 2018 Financial Results

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device...

    July 31, 2018

    Nemaura Initiates US FDA Studies, and Reports Positive Interim Data from Home-Use Portion of Study

    LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device...

    July 17, 2018

    Nemaura Places SugarBEAT® Manufacturer Order for UK Commercial Launch

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    June 13, 2018

    Nemaura Medical Inc. Reports Full Year Financial Results

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    May 30, 2018

    Nemaura Medical Signs Joint Collaboration Agreement for European Commercialization

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...

    May 15, 2018

    Nemaura Medical to Present at the UBS Global Healthcare Conference

    LOUGHBOROUGH, England–(BUSINESS WIRE)–Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing the wireless sugarBEAT® non-invasive glucose monitoring system...